Canopy Growth (CGC) Net Margin (2019 - 2025)

Canopy Growth's (CGC) quarterly Net Margin came in at 0.91% in Q1 2025, down 104.0% year-on-year from 22.86% in Q1 2024, and down 82.32% quarter-over-quarter from 5.17% in Q3 2024.

Canopy Growth (CGC) Net Margin (2019 - 2025) Analysis & Trends

Canopy Growth has disclosed Net Margin across 7 years of filings, most recently posting 0.91% for Q1 2025.

  • Net Margin for Q1 2025 came in at 0.91%, down 104.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.21% (down 202.0% YoY), and the FY2025 annual result was 1.92%, up 5778.0% from the prior year.
  • Net Margin came in at 0.91% for Q1 2025 at Canopy Growth, down from 5.17% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 250.9% in Q2 2021 to a low of 1974.84% in Q2 2022.
  • The 5-year median for Net Margin is 37.0% (2023), against an average of 188.78%.
  • Across the five-year window, Net Margin tumbled 222574 bps in 2022 and surged 193954 bps in 2023, its largest moves.
  • Canopy Growth's Net Margin stood at 74.5% in 2021, then jumped by 48 bps to 38.7% in 2022, then soared by 139 bps to 14.97% in 2023, then sank by 65 bps to 5.17% in 2024, then tumbled by 82 bps to 0.91% in 2025.
  • The last three Net Margin figures came in at 0.91% (Q1 2025), 5.17% (Q3 2024), and 2.71% (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 9.19%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 26.57%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 35.18%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 2.94%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 24.30%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 4.16%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -168.42%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.15%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 31.38%
10 Canopy Growth 11.38 Mn -137.31 Mn 15.39 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 0.91%
Sep 30, 2024 5.17%
Jun 30, 2024 2.71%
Mar 31, 2024 1.96%
Dec 31, 2023 14.97%
Sep 30, 2023 -215.21%
Jun 30, 2023 -35.30%
Mar 31, 2023 -193.23%
Dec 31, 2022 -38.70%
Sep 30, 2022 -108.87%
Jun 30, 2022 -1,974.84%
Mar 31, 2022 -277.49%
Dec 31, 2021 -74.50%
Sep 30, 2021 -12.43%
Jun 30, 2021 250.90%
Mar 31, 2021 -366.44%
Dec 31, 2020 -488.06%
Sep 30, 2020 -64.01%
Jun 30, 2020 -116.22%
Mar 31, 2020 -147.72%